1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C7352BF1B060662C00258CBD001A9CED
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-maximizing-impact-immunology-analytics-insights-teams-delivering-value-structure-branding-innovation?opendocument
18
19opendocument
2018.97.9.174
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Market Research, Analytics and Forecasting » Analytics

Maximizing the Impact of Immunology Analytics and Insights Teams: Delivering Value through Structure, Branding, and Innovation

ID: 5884


Features:

17 Info Graphics

22 Data Graphics

340+ Metrics

12 Narratives


Pages/Slides: 48


Published: 2025


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Maximizing the Impact of Immunology Analytics and Insights Teams: Delivering Value through Structure, Branding, and Innovation”

STUDY OVERVIEW

In the fast-evolving immunology landscape, Analytics & Insights (A&I) teams play a pivotal role in informing smarter strategies, shaping clinical-commercial alignment, and advancing organizational goals. To deliver maximum value, these teams must go beyond core analytics to refine how they are structured, how their impact is perceived internally, and how effectively they embed innovation across the enterprise.

This benchmarking study by Best Practices, LLC provides immunology-focused A&I leaders with peer-driven insights on optimizing team structure, elevating internal branding, and fostering a culture of innovation. The research offers a practical roadmap for increasing influence, credibility, and strategic alignment in today’s competitive immunology market.

KEY TOPICS

  • Core responsibilities and clients supported by Immunology A&I teams
  • Valuable strategic practices, skill sets, and expertise areas
  • Internal branding programs
  • Top A&I obstacles, mistakes and lessons
  • Innovative pilots, design thinking and patient engagement

KEY METRICS

  • Time allocation of Immunology A&I teams across key internal functions
  • Role played by Immunology Analytics & Insights groups in fulfilling organizational capabilities
  • Key initiatives used by Immunology A&I teams to enhance stakeholder influence and decision-making impact
  • Soft skills and prior experience backgrounds valued in Immunology A&I teams
  • Most critical technical skills for Immunology A&I professionals
  • Primary obstacles limiting the future success of Immunology A&I functions
  • Internal branding campaign rollout to shape perception of the Immunology A&I function
  • Primary goals behind internal branding initiatives in Immunology A&I
  • Extent of vendor involvement in internal branding strategy and execution
  • Use of a formal design thinking methodology in performance and innovation efforts
  • Direct patient engagement initiatives to understand real-world immunology needs
  • Disease areas where patient engagement has driven impact – by therapeutic scope (primary care, specialty, rare)
  • Disease areas where patient engagement has driven impact – by drug type and route of administration

SAMPLE KEY FINDINGS

  • Effective A&I Advisors: All immunology A&I organizations consider critical thinking skills a “must have”, while 80 - 85% say communication, interpersonal, communications and detail orientation skills are essential.

METHODOLOGY

Best Practices, LLC engaged 19 Analytics & Insights leaders across 18 leading biopharma organizations with a focus on the immunology segment. This research includes segmentation by company size (mid vs. large pharma) and features deep-dive interviews for added qualitative insights. Notably, over 35% of benchmark participants serve at the director-level or above.

Industries Profiled:
Biopharmaceutical; Pharmaceutical; Biotech; Consulting; Research; Health Care; Clinical Research; Laboratories


Companies Profiled:
Arena Pharmaceuticals; AstraZeneca; Bio-Rad Laboratories; Inc.; Biotest AG; Dermira; Decode Consulting; Grünenthal; Janssen; LEO Pharma; Lonza Inc.; MEDiSTRAVA; Merck; Momenta; Pfizer; Regeneron; Sanofi; Takeda Pharmaceuticals; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.